Analyst downgrades 5-22-07: AQNT, GSK, LMT, MSFT and SNDK
Posted May 22nd 2007 10:51AM by Kevin Shult
Filed under: Before the bell, Analyst reports, Analyst upgrades and downgrades, Bad news, Microsoft (MSFT), ALLTEL Corp (AT), Lockheed Martin (LMT), aQuantive Inc (AQNT), SanDisk Corp (SNDK)
MOST NOTEWORTHY: GlaxoSmithKline plc (GSK), SanDisk Corp (SNDK), Lockheed Martin Corp (LMT) and aQuantive, Inc (AQNT) were today's noteworthy downgrades:
- Deutsche Bank and ABN Amro cut GlaxoSmithKline (NYSE: GSK) to Hold from Buy following the New England Journal of Medicine warnings from Avandia.
- Merrill Lynch cut SanDisk (NASDAQ: SNDK) to Neutral from Buy due to concerns that oversupply in the industry will extend through next quarter.
- Cowen downgraded shares of Lockheed Martin (NYSE: LMT) to Neutral from Outperform based on slower 2007-2008 EPS growth and less cash redeployment upside than General Dynamics Corp (GD) and Raytheon Co (RTN).
- UBS downgraded aQuantive (NASDAQ: AQNT) to Neutral from Buy and RBC Capital cut shares to Sector Perform from Outperform after the Microsoft (MSFT) acquisition...
OTHER DOWNGRADES:
- Piper Jaffray downgraded Cytyc Corp (NASDAQ: CYTC) To Market Perform from Outperform.
- NetBank, Inc (NASDAQ: NTBK) was downgraded to Underperform from Market Perform at Friedman Billings.
- Gabelli downgraded shares of Alltel Corp (NYSE: AT) to Hold from Buy.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required). Tags: aeropostale, alltel, analyst, aqnt, aquantive, aro, at, bhp, cytc, cytyc, downgraded, glaxo, gsk, lockheed, microsoft, msft, netbank, ntbk, rating, sandisk, sndk, theflyonthewall.com
Nuclear power is on the comeback trail
Apple backs AT&T in continuing spat with Verizon
Closing Bell: The recession is still over, still... do you feel it?
